Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/22/2784752/0/en/Cue-Biopharma-to-Present-at-the-JMP-Securities-Hematology-and-Oncology-Summit.html

BOSTON, Nov. 22, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq:CUE), a clinical-stage biopharmaceutical company developing a novel class of T cell engagers to selectively modulate tumor-specific T cells, announced today that it will take part in a fireside chat at the JMP Securities Hematology and Oncology Summit being held virtually from December 5-6, 2023.

Read more at globenewswire.com

Related news for (CUE)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.